SPNPs combined with radiotherapy elicited anti-GBM immune response, enhanced infiltration of CD3+ and CD8+ T cells, and T cells exhibited higher levels of expression of effector molecules (eg, Granzyme B, and IFN-γ), which eventually led to tumor disappearance in 60% of mice. The gene discussed is IFNG; the disease is glioblastoma.